DailyStocks Stock Article Search

https://www.fool.com/investing/2024/10/12/2-magnificent-stocks-to-buy-that-are-near-52-week/?source=iedfolrf0000001 Oct 12, 2024 - A discounted stock can present an opportunity when there's a quality business behind it. 0

https://www.fool.com/investing/2024/09/30/2-magnificent-growth-stocks-down-45-and-32-to-buy/?source=iedfolrf0000001 Sep 30, 2024 - Sometimes, a discounted stock can present a valuable opportunity. 0

https://www.fool.com/investing/2024/09/12/3-reasons-dexcom-looks-like-a-no-brainer-buy-right/?source=iedfolrf0000001 Sep 12, 2024 - The stock isn't normally this cheap, and investors should take advantage. 0

https://www.zacks.com/stock/news/2327873/dexcom-stock-may-gain-on-expanded-reach-after-stelo-s-us-launch?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2327873 Aug 27, 2024 - DXCM announces that its OTC CGM, Stelo, is now available for purchase in the United States without a prescription. 0

https://www.fool.com/investing/2024/08/18/2-unstoppable-healthcare-stocks-to-buy-right-now/?source=iedfolrf0000001 Aug 18, 2024 - These companies' growth paths should only be briefly interrupted by headwinds. 0

https://www.zacks.com/stock/news/2323361/dexcom-s-dxcm-g7-cgm-coverage-expanded-for-quebec-residents?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2323361 Aug 16, 2024 - DexCom (DXCM) announces that Quebec residents aged two years and older living with type 1 diabetes may now be eligible to receive coverage for Dexcom G7. 0

https://www.fool.com/investing/2024/08/16/1-growth-stock-down-43-to-buy-right-now/?source=iedfolrf0000001 Aug 16, 2024 - Here's why DexCom should be on your radar after the company's share price plunged recently. 0

https://www.zacks.com/stock/news/2322671/medtronic-mdt-progresses-in-cgm-with-new-approval-alliance?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2322671 Aug 15, 2024 - The FDA approval for Medtronic's (MDT) Simplera CGM sets the stage for further regulatory submissions of the updated InPen smart insulin pen app. 0

https://www.zacks.com/stock/news/2322505/masimo-s-masi-w1-watch-gains-fda-nod-for-safetynet-connectivity?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2322505 Aug 15, 2024 - The latest FDA clearance of Masimo's (MASI) W1 medical watch is likely to provide a continuous and accurate view of patients' health data. 0

https://www.fool.com/investing/2024/07/27/2-magnificent-growth-stocks-to-buy-right-now/?source=iedfolrf0000001 Jul 27, 2024 - These top stocks are looking increasingly attractive for a long-term investment. 0